You are here

Article info

Article menu

Download PDFPDF

Commentary
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity

Authors

  • Tianyu Tang Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Xing Huang Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Gang Zhang Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  • Tingbo Liang Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of ChinaZhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou, People's Republic of ChinaThe Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou, People's Republic of ChinaDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaCancer Center, Zhejiang University, Hangzhou, People's Republic of China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xing Huang; huangxing66{at}zju.edu.cn; Dr Tingbo Liang; liangtingbo{at}zju.edu.cn
View Full Text

Citation

Tang T, Huang X, Zhang G, et al
Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
Journal for ImmunoTherapy of Cancer 2022;10:e005065. doi: 10.1136/jitc-2022-005065

Publication history

  • Accepted June 27, 2022
  • First published July 17, 2022.
Online issue publication 
October 01, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.